• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Fitbit Reportedly Looking For Buyer After Slashing 2019 Revenue Forecast

Share:

September 30, 2019

Fitbit has been on a rollercoaster of success and uncertainty since releasing their first step tracker all the way back in 2007, and now the fitness tech icon may be looking for a potential buyer. This comes after Fitbit cut its 2019 revenue forecast after sales of its newest wearables (namely the Versa Lite) were below expectations.

Fitbit has allegedly hired Qatalyst Partners, a technology-oriented boutique investment bank, to assist in putting the company up for sale. There is currently no word on a potential buyer, though Fitbit’s portfolio of fitness hardware and software – which includes assets from Pebble, Twine Health, Vector Watch, and Coin – would easily bolster a number of Alphabet’s subsidiaries.

For starters, Wear OS could greatly benefit from Fitbit’s chops in the health arena: improved heart rate tracking, insightful sleep stats, and extended battery life are just some of the areas that a Fitbit acquisition could improve.

Verily Life Sciences, Alphabet’s health-oriented arm, could also make significant use of the data and trends gleaned from Fitbit’s wide user base. For instance, leveraging Fitbit’s ambitions to identify sleep apnea via wrist-worn SpO2 sensors or understanding how users’ overall health impacts their chances of suffering from a number of major illnesses and conditions, like diabetes, hypertension, heart attack, or stroke.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Investors were pleased by the news of a potential sale: Fitbit’s stock price soared 11.7% on Friday before closing.

At the moment, there has been no official confirmation that Fitbit will move forward with offloading the company. We’ll share more details as soon as we learn them.

Date: September 30, 2019

Source: Android Police

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Biopharma Takeovers Dry upBiopharma Takeovers Dry up
  • Trending News:: COVID-19 impact on Gastrointestinal Key Market: Competitive Insights, Business Strategy Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by ForecastTrending News:: COVID-19 impact on Gastrointestinal Key Market: Competitive Insights, Business Strategy Opportunities, Future Trends, Top Key Players, Market Share and Global Analysis by Forecast
  • Baptist Health Taps TytoCare to Enhance Virtual Care to PatientsBaptist Health Taps TytoCare to Enhance Virtual Care to Patients
  • Oyster Point Pharma, A Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by ViatrisOyster Point Pharma, A Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
  • Veradigm Acquires ScienceIO | Empowering Healthcare Data InnovationVeradigm Acquires ScienceIO | Empowering Healthcare Data Innovation
  • Alimera Sciences Announces Equity Purchase Agreement for up to $20 Million with Lincoln Park CapitalAlimera Sciences Announces Equity Purchase Agreement for up to $20 Million with Lincoln Park Capital
  • JPMorgan Chase to Acquire Healthcare Payments Solution InstaMedJPMorgan Chase to Acquire Healthcare Payments Solution InstaMed
  • Roundtrip Taps Redox to Provide Complete View of Patient’s Transportation JourneyRoundtrip Taps Redox to Provide Complete View of Patient’s Transportation Journey

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications